Home   >  
Angiogenesis/Protein Tyrosine Kinase
  • Jak/Stat Pathway
  >  
EGFR
  • HER2
  >   BIBW2992 Dimaleate
BIBW2992 Dimaleate Chemical Structure

BIBW2992 Dimaleate

Data Sheet For research use only. Not for human use.
Cat. No. :BCP08915CAS No. :850140-73-7Purity:98%
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 850140-73-7 Cat. No. BCP08915
Related Products 439081-18-2(Afatinib) 850140-72-6(Afatinib)
Name BIBW2992 Dimaleate
Synonyms BIBW 2992MA2; BIBW-2992; BIBW2992; BIBW 2992; Afatinib; Afatinib dimaleate;
SMILES
Chemical Name
Formula C32H33ClFN5O11 M. Wt 718.08
Purity 98% Storage Store at 4-8°C
Description Afatinib dimaleate is an orally bioavailable dual receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. EGFR/HER2 tyrosine kinase inhibitor BIBW 2992 irreversibly binds to and inhibits human epidermal growth factor receptors 1 and 2 (EGFR-1; HER2), which may result in the inhibition of tumor growth and angiogenesis. EGFR/HER2 are RTKs that belong to the EGFR superfamily; both play major roles in tumor cell proliferation and tumor vascularization and are overexpressed in many cancer cell types. Afatinib is approved in much of the world (including the United States, Canada, the United Kingdom and Australia) for the treatment of metastatic non-small cell lung carcinoma (NSCLC), developed by Boehringer Ingelheim. It acts as an angiokinase inhibitor.
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:BIBW2992 Dimaleate supplier,BIBW2992 Dimaleate purchase,BIBW2992 Dimaleate manufacturer,BIBW2992 Dimaleate distributor,BIBW2992 Dimaleate cost,BIBW2992 Dimaleate buy,BIBW2992 Dimaleate for sale

0086-13720134139